Inventor · disambiguated record
Mark Spyvee
Also filed as: SPYVEE MARK · SPYVEE MARK REX · YANG HU
39 granted patents·13 pending applications·356 citations·filing 2003–2025
98Inventor score
Files withCV6 THERAPEUTICS NI LTD14EISAI CO LTD9EISAI R&D MAN CO LTD8UNIV SOUTHERN CALIFORNIA4BOIVIN ROCH2
Top patents by PatentIndex Score
52 records- 0197US10570098B2Hydantoin containing deoxyuridine triphosphatase inhibitorsCV6 THERAPEUTICS NI LTD·Filed 2016·Granted Feb 25, 2020·14 cites·20 claims
- 0297US10562860B2Hydantoin containing deoxyuridine triphosphatase inhibitorsCV6 THERAPEUTICS NI LTD·Filed 2018·Granted Feb 18, 2020·15 cites·12 claims
- 0396US11124485B2Deoxyuridine triphosphatase inhibitors containing cyclopropano linkageCV6 THERAPEUTICS NI LTD·Filed 2020·Granted Sep 21, 2021·4 cites·5 claims
- 0496US11104649B2Hydantoin containing deoxyuridine triphosphatase inhibitorsCV6 THERAPEUTICS NI LTD·Filed 2020·Granted Aug 31, 2021·4 cites·19 claims
- 0596US10577321B2Deoxyuridine triphosphatase inhibitorsUNIV SOUTHERN CALIFORNIA·Filed 2016·Granted Mar 3, 2020·15 cites·17 claims
- 0696US10570100B2Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkageUNIV SOUTHERN CALIFORNIA·Filed 2016·Granted Feb 25, 2020·14 cites·12 claims
- 0796US10544105B2Deoxyuridine triphosphatase inhibitors containing cyclopropano linkageCV6 THERAPEUTICS NI LTD·Filed 2016·Granted Jan 28, 2020·14 cites·10 claims
- 0895US11198677B2Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkageUNIV SOUTHERN CALIFORNIA·Filed 2020·Granted Dec 14, 2021·4 cites·17 claims
- 0994US12098133B2Hydantoin containing deoxyuridine triphosphatase inhibitorsCV6 THERAPEUTICS NI LTD·Filed 2022·Granted Sep 24, 2024·1 cites·19 claims
- 1094US10858344B2Hydantoin containing deoxyuridine triphosphatase inhibitorsCV6 THERAPEUTICS NI LTD·Filed 2017·Granted Dec 8, 2020·8 cites·6 claims
- 1194US10829457B2Nitrogen ring linked deoxyuridine triphosphatase inhibitorsCV6 THERAPEUTICS NI LTD·Filed 2017·Granted Nov 10, 2020·8 cites·14 claims
- 1294US7585976B2Hemiasterlin derivatives and uses thereofEISAI CO LTD·Filed 2006·Granted Sep 8, 2009·13 cites·10 claims
- 1393US7528152B2Hemiasterlin derivatives and uses thereof in the treatment of cancerEISAI CO LTD·Filed 2007·Granted May 5, 2009·19 cites·26 claims
- 1493US7064211B2Hemiasterlin derivatives and uses thereofEISAI CO LTD·Filed 2003·Granted Jun 20, 2006·28 cites·18 claims
- 1592US8354400B2Benzoxazole compounds and methods of useEISAI R&D MAN CO LTD·Filed 2009·Granted Jan 15, 2013·29 cites·21 claims
- 1690US8129407B2Hemiasterlin derivatives and uses thereof in the treatment of cancerKOWALCZYK JAMES J·Filed 2009·Granted Mar 6, 2012·15 cites·22 claims
- 1790US7550501B2Compounds and methods for treating toll-like receptor 2-related diseases and conditionsEISAI R&D MAN CO LTD·Filed 2007·Granted Jun 23, 2009·18 cites·34 claims
- 1889US11584723B2Hydantoin containing deoxyuridine triphosphatase inhibitorsCV6 THERAPEUTICS NI LTD·Filed 2021·Granted Feb 21, 2023·1 cites·20 claims
- 1989US11168059B2Amino sulfonyl compoundsCV6 THERAPEUTICS NI LTD·Filed 2017·Granted Nov 9, 2021·4 cites·18 claims
- 2089US11014924B2Hydantoin containing deoxyuridine triphosphatase inhibitorsCV6 THERAPEUTICS NI LTD·Filed 2017·Granted May 25, 2021·4 cites·6 claims
- 2189US8633224B2Hemiasterlin derivatives and uses thereof in the treatment of cancerKOWALCZYK JAMES J·Filed 2012·Granted Jan 21, 2014·12 cites·20 claims
- 2288US11174271B26-membered uracil isosteresCV6 THERAPEUTICS NI LTD·Filed 2017·Granted Nov 16, 2021·4 cites·7 claims
- 2388US2025188039A1Hydantoin containing deoxyuridine triphosphatase inhibitorsCV6 THERAPEUTICS NI LTD·Filed 2024·Application pending·0 cites
- 2486US7192972B2Hemiasterlin derivatives and uses thereofEISAI CO LTD·Filed 2003·Granted Mar 20, 2007·18 cites·21 claims
- 2585US7666875B2Hydantoin compoundsEISAI R&D MAN CO LTD·Filed 2006·Granted Feb 23, 2010·11 cites·30 claims
- 2684US8329742B2Macrocyclic compounds useful as pharmaceuticalsBOIVIN ROCH·Filed 2010·Granted Dec 11, 2012·9 cites·32 claims
- 2784US7202234B2Compounds and methods for treating Toll-like receptor 2-related diseases and conditionsEISAI CO LTD·Filed 2004·Granted Apr 10, 2007·18 cites·35 claims
- 2882US7799827B2Macrocyclic compounds useful as pharmaceuticalsEISAI CO LTD·Filed 2003·Granted Sep 21, 2010·16 cites·30 claims
- 2980US8686018B2Pharmaceutical compositionEISAI R&D MAN CO LTD·Filed 2013·Granted Apr 1, 2014·5 cites·24 claims
- 3078US10501413B2Inhibitors of the Notch transcriptional activation complex and methods for use of the sameUNIV MIAMI·Filed 2016·Granted Dec 10, 2019·3 cites·16 claims
- 3178US9000024B2Pharmaceutical compositionEISAI R&D MAN CO LTD·Filed 2014·Granted Apr 7, 2015·4 cites·71 claims
- 3277US7915306B2Macrocyclic compounds useful as pharmaceuticalsEISAI CO LTD·Filed 2003·Granted Mar 29, 2011·13 cites·92 claims
- 3376US7314936B2Deazapurines and uses thereofEISAI CO LTD·Filed 2003·Granted Jan 1, 2008·8 cites·34 claims
- 3473US7838548B2Compounds and methods for treating toll-like receptor 2-related diseases and conditionsEISAI R&D MAN CO LTD·Filed 2009·Granted Nov 23, 2010·1 cites·7 claims
- 3572US7985746B2Imidazoazepinone compoundsEISAI R&D MAN CO LTD·Filed 2007·Granted Jul 26, 2011·1 cites·10 claims
- 3664US11518746B2Nitrogen ring linked deoxyuridine triphosphatase inhibitorsCV6 THERAPEUTICS NI LTD·Filed 2020·Granted Dec 6, 2022·0 cites·15 claims
- 3763US8691814B2Deazapurines and uses thereofDAUN JANE·Filed 2010·Granted Apr 8, 2014·1 cites·35 claims
- 3861US11479531B2Deoxyuridine triphosphatase inhibitorsUNIV SOUTHERN CALIFORNIA·Filed 2020·Granted Oct 25, 2022·0 cites·19 claims
- 3961US7868002B2Deazapurines and uses thereofEISAI R&D MAN CO LTD·Filed 2007·Granted Jan 11, 2011·0 cites·31 claims
- 4061US2014309174A1Hemiasterlin derivatives and uses thereof in the treatment of cancerEISAI CO LTD·Filed 2013·Application pending·0 cites
- 4160US2022281863A1Compounds, compositions and methods of treating disordersREVERIE LABS INC·Filed 2022·Application pending·0 cites
- 4253US12275725B2Inhibitors of the notch transcriptional activation complex and methods for use of the sameUNIV MIAMI·Filed 2020·Granted Apr 15, 2025·0 cites·20 claims
- 4353US2008108820A1Hemiasterlin Derivatives and Uses ThereofCAMPAGNA SILVIO A·Filed 2004·Application pending·0 cites
- 4451US2011130349A1Compounds and Methods for Treating Toll-Like Receptor 2-Related Diseases and ConditionsCHOW JESSE·Filed 2010·Application pending·0 cites
- 4551US2013196987A1Macrocyclic compounds useful as pharmaceuticalsBOIVIN ROCH·Filed 2012·Application pending·0 cites
- 4651US2011065916A1Method of making imidazoazepinone compoundsSPYVEE MARK·Filed 2008·Application pending·0 cites
- 4750US2010305098A1Methods of useCHEN QIAN·Filed 2008·Application pending·0 cites
- 4848US2009197867A1Enantiomerically enriched imidazoazepinone compoundsSPYVEE MARK·Filed 2008·Application pending·0 cites
- 4947US2009233906A1Imidazoazepinone compoundsFANG FRANCIS·Filed 2007·Application pending·0 cites
- 5041US2025257061A1Compositions and methods for treating cancer and reducing wnt mediated effectsSTEMSYNERGY THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Mark Spyvee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →